Home / Auditor changes / Petros Pharmaceuticals, Inc.
Filed 2025-04-09 路 Form 8-K 路 Accession 0001104659-25-033391 nano
Price before filing: $1.37 (2025-04-08 close, split/dividend-adjusted)
Market cap at flag: $33.7M (2025-04-09) 路 Latest: $127,958 (2026-10-16)
| Window | PTPI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -91.2% | +13.7% | -104.9% | 2025-05-09 |
| 90 days | -97.8% | +25.3% | -123.1% | 2025-07-08 |
| 180 days | -98.3% | +36.1% | -134.4% | 2025-10-06 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On April 5, 2025, the Company terminated its relationship with Marcum as the Company's independent registered accounting firm and, with the approval of the Audit Committee of the Company's Board of Directors, engaged CBIZ CPAs as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: changed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.